Publicacións nas que colabora con MARIA CLARA ALVAREZ VILLAMARIN (35)

2022

  1. LEAP-2 Counteracts Ghrelin-Induced Food Intake in a NutrientGrowth Hormone and Age Independent Manner

    Cells, Vol. 11, Núm. 3

2021

  1. Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling

    Cancers, Vol. 13, Núm. 16

  2. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas

    Oncogene, Vol. 40, Núm. 45, pp. 6354-6368

2018

  1. Protamine nanocapsules as carriers for oral peptide delivery

    Journal of Controlled Release, Vol. 291, pp. 157-168

2016

  1. Pharmacological and genetic manipulation of p53 in brown fat at adult but not embryonic stages regulates thermogenesis and body weight in male mice

    Endocrinology, Vol. 157, Núm. 7, pp. 2735-2749

2015

  1. Pituitary Cell Turnover: From Adult Stem Cell Recruitment through Differentiation to Death

    Neuroendocrinology, Vol. 101, Núm. 3, pp. 175-192

2014

  1. Hypothalamic effects of thyroid hormones on metabolism

    Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 28, Núm. 5, pp. 703-712

  2. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF

    Endocrinology, Vol. 155, Núm. 11, pp. 4329-4340

2013

  1. Energy balance regulation by thyroid hormones at central level

    Trends in Molecular Medicine, Vol. 19, Núm. 7, pp. 418-427

  2. The orexigenic effect of orexin-A revisited: Dependence of an intact growth hormone axis

    Endocrinology, Vol. 154, Núm. 10, pp. 3589-3598

2012

  1. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1

  2. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

    Oncogene, Vol. 31, Núm. 23, pp. 2824-2835

2009

  1. A GRFa2/Prop1/Stem (GPS) cell niche in the pituitary

    PLoS ONE, Vol. 4, Núm. 3

2008

  1. GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression

    Journal of Cellular Physiology, Vol. 215, Núm. 1, pp. 140-150

  2. Ghrelin localization in the medulla of rat and human adrenal gland and in pheochromocytomas

    Histology and Histopathology, Vol. 23, Núm. 1, pp. 57-65

  3. Hypothalamic Fatty Acid Metabolism Mediates the Orexigenic Action of Ghrelin

    Cell Metabolism, Vol. 7, Núm. 5, pp. 389-399

2007

  1. Role of ghrelin in reproduction

    Reproduction, Vol. 133, Núm. 3, pp. 531-540

  2. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth

    EMBO Journal, Vol. 26, Núm. 8, pp. 2015-2028

2003

  1. Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland

    Endocrinology, Vol. 144, Núm. 11, pp. 5089-5097

2002

  1. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 87, Núm. 4, pp. 1879-1884